PRAX סך נכסי הפעילות העסקית Praxis Precision Medicines Inc
Praxis Precision Medicines (PRAX) is a leading developer of targeted therapies for CNS pathologies with a robust scientific and technical foundation in the fight against epilepsy. This price chart reflects total assets at 921.55. The operating model relies on an extensive network of external laboratories, which mitigates the risks of dependency on a single contractor. Simultaneously, Praxis Precision Medicines (PRAX) is building a foundation for long-term dominance by focusing on unique genetic brain modifications.
פילוחים אנליטיים ודוחות נתונים של חברת Praxis Medicines (PRAX)
Since Praxis Precision Medicines (PRAX) delegates drug production to third-party CMOs to focus on R&D, the value of total assets reflects the capitalization of intellectual and financial resources rather than physical plants. This indicator, reverse-calculated via ROA, digitizes the total value of assets and liabilities, where high line volatility signals instability in the capital base and elevated investment risks.